Halaman 5 - Kanker payudara Dokter Terbaik - TOP-171 dokter

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Kinas berspesialisasi dalam bedah payudara dan prosedur onkologi, menawarkan perawatan ahli di Rumah Sakit Büyük Anadolu.

• Berpengalaman dalam berbagai bedah kanker termasuk payudara, pankreas, dan kolon
• Ahli dalam bedah metabolik bariatrik dan diabetes
• Fokus pada rencana perawatan kanker yang komprehensif

Dr. Tamer Mostafa Manie is an Associate Professor of Surgical Oncology at the National Cancer Institute, Cairo University. He is also a Consultant Breast and Oncoplastic Surgeon at Shefa Al Orman. He performs breast cancer surgery and reconstruction. His work includes CBS, mastectomy, and lumpectomy. He performs sentinel and axillary staging. He offers implant and expander reconstruction and flap options (LD, TDAP, LICAP, AICAP, TRAM, SEAP). He also performs supermicrosurgery for lymphedema. He was Breast Cancer MDT Chairman at Madinet Nasr Oncology Center from 2021 to 2023.

Qualifications: MBBCh (2003), Master’s in Surgical Oncology (2009), Doctorate in Surgical Oncology (2014). International training: Heart of England NHS Trust (2013), European Institute of Oncology, Milan (2013–2014), Nottingham Breast Institute (2023). Memberships: EGSSO and the European Society of Surgical Oncology.

Dr. Kaduri berspesialisasi dalam penelitian kanker payudara terkait BRCA, dengan studi yang dipublikasikan tentang Oncotype Dx pada pembawa BRCA1/2. Beliau bekerja di Hadassah Medical Center.

• Melakukan penelitian terobosan di The Royal Marsden Hospital
• Mempublikasikan tentang mutasi TP53 pada pasien keturunan Arab
• Menjadi penerima penghargaan Cancer Genetics Research Foundation Award
• Menjadi anggota dari Israeli Society of Clinical Oncology

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Spesialis dalam perawatan kanker payudara dengan keahlian dari Universitas Hacettepe – salah satu pusat onkologi terkemuka di Turki.

• Spesialis onkologi medis dengan pengalaman di Rumah Sakit Onkologi Fakultas Kedokteran Universitas Hacettepe
• Anggota penuh ESMO (European Society for Medical Oncology)
• Menempuh pendidikan di Fakultas Kedokteran Universitas Ankara
• Mengobati kanker seluran pencernaan, limfoma, dan sarkoma

Dr. Tarek M. Hashem is an Associate Professor of Surgical Oncology at the National Cancer Institute, Cairo University (since 2020). He is also a Consultant in Breast and Oncoplastic Surgery at Shefa Al Orman Comprehensive Cancer Center in Luxor (2018–present).

Focus: breast cancer management and oncoplastic surgery. Procedures include breast-conserving surgery, mastectomy, and lumpectomy. Axillary staging includes sentinel lymph node biopsy and axillary dissection. He performs reduction mammoplasty and mastopexy. Reconstruction options include implants, expanders, and flaps (LD, TDAP, LICAP, AICAP, TRAM, SEAP), as well as nipple reconstruction and lipofilling. He also performs supermicrosurgery for lymphedema.

Credentials: MBBCh (Kasr El-Aini, Cairo University). MRCS (England, 2008). Master’s in General Surgery (Kasr El-Aini, Cairo University, 2009). International Breast Surgery Fellowship per EUSOMA (Marienhospital Düsseldorf, 2011). Fellowship in Breast Surgery (Heidelberg University Hospital, 2013). Doctoral degree in Surgical Oncology (2015).

322 publikasi peer-review – Dr. Kuemmel mengepalai Unit Payudara Multidisiplin Jerman di Kliniken Essen-Mitte.

• Direktur Klinis dari salah satu pusat kanker payudara terbaik di Jerman
• Anggota Dewan Eksekutif Arbeitsgemeinschaft Gynäkologische Onkologie
• Fakultas ESMO dengan 1.032 kuliah tamu di seluruh dunia
• Spesialisasi dalam program perawatan kanker payudara holistik

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Leng Yin berspesialisasi dalam mengobati kanker payudara serta onkologi hati, kantong empedu, dan pankreas di Rumah Sakit Kanker Fuda.

• Onkolog di Rumah Sakit Internasional Bumrungrad dan Rumah Sakit Royal Siriraj di Thailand
• Anggota Asosiasi Anti-Kanker Tiongkok
• Keahlian dalam berbagai pengobatan onkologi gastrointestinal dan payudara

Dr. Rinat Erushalmi berspesialisasi dalam kanker payudara di Rabin Medical Center, dengan keahlian dalam Kanker Payudara HER-2 Positif dan Triple-Negatif.

• Peringkat tinggi dalam 6 kondisi termasuk kanker payudara
• Ahli dalam Terapi Penggantian Hormon dan Ooforektomi
• Berpraktik di Rabin Medical Center di Petach Tikva, Israel

25 tahun spesialisasi dalam kanker payudara – Dr. Viktoriya Nejman mengepalai departemen bedah onkologi di Rabin Medical Center di Israel.

• Ahli dalam kemoterapi dan perawatan bedah untuk kanker payudara
• Anggota masyarakat onkologi nasional dan internasional
• Memimpin studi klinis dalam onkourologi
• Sering diundang sebagai pembicara di forum onkologi internasional

Dr. Prat berspesialisasi dalam ekspresi gen dan subtipe molekuler kanker payudara, merancang perawatan baru di SOLTI. Penelitiannya secara langsung menginformasikan perawatan pasien.

• Kepala Genomik Translasional di IDIBAPS
• Presiden SOLTI – memimpin uji klinis kanker payudara
• Lebih dari 160 publikasi dengan 13.479 sitasi
• Profesor tetap di Universitas Barcelona

Onkoginekolog dengan keahlian kanker payudara di Samsung Medical Center.

• Spesialisasi dalam kanker ginekologi dan kanker payudara
• Berafiliasi dengan pusat medis terkemuka di Korea Selatan
• Fokus pada perawatan kanker yang komprehensif

Seung Jae Huh adalah seorang onkolog berdedikasi di Samsung Medical Center yang berspesialisasi dalam kanker payudara.

• Berspesialisasi dalam pengobatan kanker payudara
• Berpraktik di Samsung Medical Center

Onkolog spesialis kanker payudara di Samsung Medical Center.

• Mendiagnosis dan mengobati berbagai jenis kanker payudara
• Bekerja di salah satu pusat medis terkemuka di Korea Selatan
• Berfokus pada penyusunan rencana perawatan yang dipersonalisasi